INTRODUCTION: We have previously reported that 1 year of supervised resistance + impact training stopped bone loss and built muscle strength in older breast cancer survivors. The purpose of this study was to determine whether these benefits persisted 1 year after completion of the intervention. METHODS:Sixty-seven women from the original trial completed baseline and post-intervention body composition and muscle strength tests, and 44 women were available 1 year later for follow-up assessments. Bone mineral density (grams per square centimeter) of the hip and spine, muscle mass (kilograms), and fat mass (kilograms) were measured by dual-energy X-ray absorptiometry and maximal upper and lower body strength were measured by one-repetition maximum tests (kilograms). We compared between group changes across baseline (pre-intervention), 1 (post-intervention), and 2 years (1 year follow up) on study outcomes using repeated-measures analysis of covariance, adjusting for age. RESULTS: Significant group by time interactions were found for spine bone mineral density (BMD) (p < 0.01) and lower body muscle strength (p < 0.05), with a trend for upper body muscle strength (p = 0.05). Spine BMD remained stable across intervention and follow-up periods in exercisers compared with continuous losses in controls across 1- and 2-year periods. In contrast, lower body strength increased in exercisers across the intervention, but decreased to near-baseline levels during follow-up compared with no change over either time period in controls. CONCLUSIONS: Our data suggest that spine BMD can be preserved in older breast cancer survivors even after formal exercise training stops; however, muscle strength is not similarly maintained and may require continued participation in a supervised exercise program. IMPLICATIONS FOR CANCER SURVIVORS: Exercise programs aimed at improving musculoskeletal health should be considered in the long-term care plan for breast cancer survivors.
RCT Entities:
INTRODUCTION: We have previously reported that 1 year of supervised resistance + impact training stopped bone loss and built muscle strength in older breast cancer survivors. The purpose of this study was to determine whether these benefits persisted 1 year after completion of the intervention. METHODS: Sixty-seven women from the original trial completed baseline and post-intervention body composition and muscle strength tests, and 44 women were available 1 year later for follow-up assessments. Bone mineral density (grams per square centimeter) of the hip and spine, muscle mass (kilograms), and fat mass (kilograms) were measured by dual-energy X-ray absorptiometry and maximal upper and lower body strength were measured by one-repetition maximum tests (kilograms). We compared between group changes across baseline (pre-intervention), 1 (post-intervention), and 2 years (1 year follow up) on study outcomes using repeated-measures analysis of covariance, adjusting for age. RESULTS: Significant group by time interactions were found for spine bone mineral density (BMD) (p < 0.01) and lower body muscle strength (p < 0.05), with a trend for upper body muscle strength (p = 0.05). Spine BMD remained stable across intervention and follow-up periods in exercisers compared with continuous losses in controls across 1- and 2-year periods. In contrast, lower body strength increased in exercisers across the intervention, but decreased to near-baseline levels during follow-up compared with no change over either time period in controls. CONCLUSIONS: Our data suggest that spine BMD can be preserved in older breast cancer survivors even after formal exercise training stops; however, muscle strength is not similarly maintained and may require continued participation in a supervised exercise program. IMPLICATIONS FOR CANCER SURVIVORS: Exercise programs aimed at improving musculoskeletal health should be considered in the long-term care plan for breast cancer survivors.
Authors: Zhao Chen; Michael Maricic; Tamsen L Bassford; Mary Pettinger; Cheryl Ritenbaugh; Ana Maria Lopez; David H Barad; Margery Gass; Meryl S Leboff Journal: Arch Intern Med Date: 2005-03-14
Authors: Lawrence H Kushi; Colleen Doyle; Marji McCullough; Cheryl L Rock; Wendy Demark-Wahnefried; Elisa V Bandera; Susan Gapstur; Alpa V Patel; Kimberly Andrews; Ted Gansler Journal: CA Cancer J Clin Date: 2012 Jan-Feb Impact factor: 508.702
Authors: Colleen Doyle; Lawrence H Kushi; Tim Byers; Kerry S Courneya; Wendy Demark-Wahnefried; Barbara Grant; Anne McTiernan; Cheryl L Rock; Cyndi Thompson; Ted Gansler; Kimberly S Andrews Journal: CA Cancer J Clin Date: 2006 Nov-Dec Impact factor: 508.702
Authors: Fred Saad; Jonathan D Adachi; Jacques P Brown; Leah A Canning; Karen A Gelmon; Robert G Josse; Kathleen I Pritchard Journal: J Clin Oncol Date: 2008-10-27 Impact factor: 44.544
Authors: R J Freedman; N Aziz; D Albanes; T Hartman; D Danforth; S Hill; N Sebring; J C Reynolds; J A Yanovski Journal: J Clin Endocrinol Metab Date: 2004-05 Impact factor: 5.958
Authors: Miriam C Morey; Cindy K Blair; Richard Sloane; Harvey Jay Cohen; Denise C Snyder; Wendy Demark-Wahnefried Journal: Cancer Date: 2015-10-29 Impact factor: 6.860
Authors: Hawley C Almstedt; Silvie Grote; Joshua R Korte; Stephanie Perez Beaudion; Todd C Shoepe; Sarah Strand; Heather P Tarleton Journal: Bone Rep Date: 2016-09-21
Authors: Kellie Toohey; Kate Pumpa; Andrew McKune; Julie Cooke; Marijke Welvaert; Joseph Northey; Clare Quinlan; Stuart Semple Journal: BMC Cancer Date: 2020-08-20 Impact factor: 4.430